Guidelines for the hormone treatment of women in the menopausal transition and beyondPosition statement by the Executive Committee of the International Menopause Society
- 1 January 2004
- journal article
- guideline
- Published by Taylor & Francis in Climacteric
- Vol. 7 (1) , 8-11
- https://doi.org/10.1080/13697130310001651427
Abstract
(2004). Guidelines for the hormone treatment of women in the menopausal transition and beyondPosition statement by the Executive Committee of the International Menopause Society. Climacteric: Vol. 7, No. 1, pp. 8-11.Keywords
This publication has 11 references indexed in Scilit:
- Estrogen plus Progestin and the Risk of Coronary Heart DiseaseNew England Journal of Medicine, 2003
- Breast cancer and hormone-replacement therapy in the Million Women StudyThe Lancet, 2003
- Effects of Estrogen plus Progestin on Health-Related Quality of LifeNew England Journal of Medicine, 2003
- Does elevated body mass modify the influence of postmenopausal estrogen replacement on atherosclerosis progression: results from the estrogen in the prevention of atherosclerosis trialAtherosclerosis, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Trends in the Incidence of Coronary Heart Disease and Changes in Diet and Lifestyle in WomenNew England Journal of Medicine, 2000
- Effects of Estrogen Replacement on the Progression of Coronary-Artery AtherosclerosisNew England Journal of Medicine, 2000
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Postmenopausal Hormone Therapy and MortalityNew England Journal of Medicine, 1997
- Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990